Targeting of Prosurvival Pathways as Therapeutic Approaches against Primary Effusion Lymphomas: Past, Present, and Future

Constitutively activated prosurvival pathways render cancer cells addicted to their effects. Consequently they turn out to be the Achilles' heels whose inhibition can be exploited in anticancer therapy. Primary effusion lymphomas (PELs) are very aggressive non-Hodgkin's B cell lymphomas, w...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Biomed Res Int
Autores principales: Granato, Marisa, Santarelli, Roberta, Gonnella, Roberta, Farina, Antonella, Trivedi, Pankaj, Faggioni, Alberto, Cirone, Mara
Formato: Artigo
Lenguaje:Inglês
Publicado: Hindawi Publishing Corporation 2015
Materias:
Review Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4324489/
https://ncbi.nlm.nih.gov/pubmed/25695042
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/104912
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares